Form 4: Former CFO's ZVRA Stock Transactions Post-Departure
Insider Transaction Report
Former Zevra Therapeutics CFO LaDuane Clifton reported the vesting and subsequent tax-related disposition of company stock following his departure on December 31, 2025.
Summary
- Clifton R. LaDuane, former CFO and Treasurer of Zevra Therapeutics, Inc. (ZVRA), reported transactions related to his beneficial ownership of company stock.
- On December 31, 2025, 140,667 shares of common stock were acquired upon the vesting of restricted stock units (RSUs) and performance stock units (PSUs).
- Concurrently, 48,513 shares of common stock were disposed of at a price of $8.96 per share to cover withholding taxes for the vested units.
- The vesting of all restricted stock units and performance stock units was accelerated due to Mr. LaDuane's departure from the company on December 31, 2025.
- Following these transactions, Mr. LaDuane beneficially owns 143,515 shares of Zevra Therapeutics common stock.
Sentiment
Score: 5
Explanation: The filing is a routine Form 4 reporting the vesting and tax-related disposition of equity awards by a former executive, which is a standard event following a departure. It does not contain information that would significantly alter the company's fundamental outlook.
Positives
- Vesting of 140,667 shares of common stock from restricted stock units and performance stock units, representing a realization of equity compensation for the former executive.
Negatives
- Disposition of 48,513 shares of common stock at $8.96 per share to cover withholding taxes, reducing the former executive's direct holdings.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| CFO & Treasurer | Clifton R. LaDuane | NA | 12/31/2025 | Departure from the company, leading to accelerated vesting of equity awards. |
Stakeholder Impact
- Shareholders: The transactions represent a routine change in an insider's holdings following departure, with a minor increase in the public float from vested shares, partially offset by shares withheld for taxes. This is unlikely to have a significant impact on the company's share price or operations.
- Employees: No direct impact on current employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of earliest transaction, including the vesting of restricted stock units and performance stock units, and the departure of the reporting person from the company. |
| 01/07/2026 | Signature date of the reporting person for the filing. |
Keywords
ZEVRA, ZVRA, Form 4, insider transaction, equity vesting, restricted stock units, performance stock units, CFO departure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.